NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
Clinical trials for NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a new scan spot returning cancer sooner?
Diagnosis Recruiting nowThis study is testing if a new type of imaging scan can better detect multiple myeloma, a blood cancer, compared to the scan currently used. Researchers want to see if this new scan can find returning disease earlier, which could help doctors start treatment sooner. About 60 adul…
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC
-
Tracking 500 cancer patients to map Real-World treatment results
Knowledge-focused Recruiting nowThis study aims to understand how newly diagnosed multiple myeloma patients in China respond to first-line immunotherapy treatments in everyday medical practice. Researchers will follow 500 patients for one year to collect information about their treatment choices, how well the t…
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Apr 04, 2026 03:49 UTC